{"transactions":[{"id":685847,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-08-17T21:00:11.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On July 23, 2026, the Issuer filed a Current Report on Form 8-K reporting that the Reporting Person was entitled to receive pursuant to her employment offer letter 65,000 restricted stock units (\"RSUs\") and 95,000 stock options. It was subsequently determined that in lieu of the foregoing grants which had not yet been made, the Reporting Person would receive 104,000 restricted stock units in the aggregate and 56,000 options (the \"Options\"). These updated awards were granted on August 14, 2026 and are reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Options vest over four years, with 25% of the shares vesting on July 20, 2027, and the remaining shares vesting in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer through each such vesting date."}],"balance_after":56000,"derivative":{"exercise_price":5.84,"expiration_date":"2036-08-13","underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0002064348-26-000003","document":"form4-08172026_050801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000206434826000003/form4-08172026_050801.xml","form_type":"4"}},{"id":685846,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-17T21:00:11.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On July 23, 2026, the Issuer filed a Current Report on Form 8-K reporting that the Reporting Person was entitled to receive pursuant to her employment offer letter 65,000 restricted stock units (\"RSUs\") and 95,000 stock options. It was subsequently determined that in lieu of the foregoing grants which had not yet been made, the Reporting Person would receive 104,000 restricted stock units in the aggregate and 56,000 options (the \"Options\"). These updated awards were granted on August 14, 2026 and are reported herein."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of the Issuer's Common Stock underlying RSUs. Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of RSUs will vest and settle into Common Stock on July 20, 2027, and the remaining RSUs will vest in a series of 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer through each such vesting date."}],"balance_after":104000,"source":{"system":"sec-edgar","filing":"0002064348-26-000003","document":"form4-08172026_050801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000206434826000003/form4-08172026_050801.xml","form_type":"4"}},{"id":685845,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-17T21:00:11.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On July 23, 2026, the Issuer filed a Current Report on Form 8-K reporting that the Reporting Person was entitled to receive pursuant to her employment offer letter 65,000 restricted stock units (\"RSUs\") and 95,000 stock options. It was subsequently determined that in lieu of the foregoing grants which had not yet been made, the Reporting Person would receive 104,000 restricted stock units in the aggregate and 56,000 options (the \"Options\"). These updated awards were granted on August 14, 2026 and are reported herein."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of the Issuer's Common Stock underlying RSUs. Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of RSUs will vest and settle into Common Stock on July 20, 2027, and the remaining RSUs will vest in a series of 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer through each such vesting date."}],"balance_after":65000,"source":{"system":"sec-edgar","filing":"0002064348-26-000003","document":"form4-08172026_050801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000206434826000003/form4-08172026_050801.xml","form_type":"4"}},{"id":770308,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-05-20T21:24:23.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":2414,"price":9.1286,"value":22036.4404,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $9.12 to $9.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":49636,"source":{"system":"sec-edgar","filing":"0000905148-26-002570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000090514826002570/form4.xml","form_type":"4"}},{"id":849157,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-11T21:45:38.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":20300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") vest as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the second Quarterly Vesting Date (as defined below) following March 9, 2026, and as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the next seven Quarterly Vesting Dates, such that all of the shares subject to the RSUs shall be vested on the last Quarterly Vesting Date, subject to the reporting person's continuous employment. \"Quarterly Vesting Date\" means March 1, May 15, August 15, and November 15 of each year, provided that if such date falls on a weekend or holiday, the Quarterly Vesting Date shall be the first business day after such date."}],"balance_after":52050,"source":{"system":"sec-edgar","filing":"0000905148-26-001224","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000090514826001224/form4.xml","form_type":"4"}},{"id":862400,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:28:21.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":100,"price":5.083,"value":508.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 2, 2026 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":31750,"source":{"system":"sec-edgar","filing":"0000905148-26-001144","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000090514826001144/form4.xml","form_type":"4"}},{"id":862399,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:28:21.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":377,"price":5.082,"value":1915.914,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 2, 2026 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":31850,"source":{"system":"sec-edgar","filing":"0000905148-26-001144","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000090514826001144/form4.xml","form_type":"4"}},{"id":862398,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:28:21.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1603,"price":5.081,"value":8144.843,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 2, 2026 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":32227,"source":{"system":"sec-edgar","filing":"0000905148-26-001144","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000090514826001144/form4.xml","form_type":"4"}},{"id":862397,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:28:21.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":24,"price":5.077,"value":121.848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 2, 2026 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 400 shares purchased under the Issuer's Employee Stock Purchase Plan on November 28, 2025."}],"balance_after":33830,"source":{"system":"sec-edgar","filing":"0000905148-26-001144","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000090514826001144/form4.xml","form_type":"4"}},{"id":994252,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-19T21:55:00.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":74,"price":13.191,"value":976.134,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 17, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":33454,"source":{"system":"sec-edgar","filing":"0000905148-25-004140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000090514825004140/form4.xml","form_type":"4"}},{"id":994251,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-19T21:55:00.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":85,"price":13.188,"value":1120.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 17, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":33528,"source":{"system":"sec-edgar","filing":"0000905148-25-004140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000090514825004140/form4.xml","form_type":"4"}},{"id":994250,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-19T21:55:00.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":1645,"price":13.186,"value":21690.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 17, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":33613,"source":{"system":"sec-edgar","filing":"0000905148-25-004140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000090514825004140/form4.xml","form_type":"4"}},{"id":1060525,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-08-20T20:08:26.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":1668,"price":11.614,"value":19372.152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 18, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":35258,"source":{"system":"sec-edgar","filing":"0000905148-25-003069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000090514825003069/form4.xml","form_type":"4"}},{"id":1060524,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-08-20T20:08:26.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":86,"price":11.613,"value":998.718,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 18, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":36926,"source":{"system":"sec-edgar","filing":"0000905148-25-003069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000090514825003069/form4.xml","form_type":"4"}},{"id":1060523,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-08-20T20:08:26.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":55,"price":11.609,"value":638.495,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 18, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":37012,"source":{"system":"sec-edgar","filing":"0000905148-25-003069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000090514825003069/form4.xml","form_type":"4"}},{"id":1140783,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":22991,"kind":"person","name":"Grant-Huerta Yanina","position":1,"cik":"0002064348","reported_name":"Grant-Huerta Yanina","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-05-20T20:59:06.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":2218,"price":6.763,"value":15000.334,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2025 and May 19, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":37067,"source":{"system":"sec-edgar","filing":"0000905148-25-001866","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2064348/000090514825001866/form4.xml","form_type":"4"}}]}